The Global Fund's Malaria Medicine Subsidy: A Nice Idea with Nasty Implications
Africa Fighting Malaria Policy Paper
22 Pages Posted: 22 Oct 2013
Date Written: September 8, 2011
Phase 1 of the Affordable Medicines Facility for malaria (AMFm) is a $225 million initiative that was launched in 2010 in an effort to increase access to safe and effective artemisinin-based combination therapies (ACTs) by dramatically lowering their price with a global subsidy. The AMFm also seeks to drive out oral artemisinin monotherapies as their continued use threatens the entire class of drugs due to drug resistance.
Suggested Citation: Suggested Citation